Back to top
more

CryoPort (CYRX)

(Delayed Data from NSDQ)

$16.81 USD

16.81
220,198

+0.43 (2.63%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $16.81 0.00 (0.00%) 6:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 12% (223 out of 252)

Industry: Transportation - Services

Better trading starts here.

Zacks News

Earnings Preview: CryoPort, Inc. (CYRX) Q1 Earnings Expected to Decline

CryoPort (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -59.38% and 1.74%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate CryoPort, Inc. (CYRX) to Report a Decline in Earnings: What to Look Out for

CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Hub Group (HUBG) Q4 Earnings Surpass Estimates

Hub Group (HUBG) delivered earnings and revenue surprises of 3.85% and 0.68%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Expeditors International (EXPD) Lags Q3 Earnings and Revenue Estimates

Expeditors International (EXPD) delivered earnings and revenue surprises of -7.20% and 5.75%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate CryoPort, Inc. (CYRX) to Report a Decline in Earnings: What to Look Out for

CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for August 21st

ALPMY, CYRX and DRCT have been added to the Zacks Rank #5 (Strong Sell) List on August 21, 2023.

CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -68% and 0.14%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Daseke (DSKE) Misses Q2 Earnings and Revenue Estimates

Daseke (DSKE) delivered earnings and revenue surprises of -70.83% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Hub Group (HUBG) Beats Q2 Earnings Estimates

Hub Group (HUBG) delivered earnings and revenue surprises of 2.13% and 6.91%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of 11.11% and 1.39%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Trinity Industries (TRN) Misses Q1 Earnings Estimates

Trinity Industries (TRN) delivered earnings and revenue surprises of -78.13% and 10.64%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Will CryoPort, Inc. (CYRX) Report Negative Q1 Earnings? What You Should Know

CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -14.29% and 4.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

C.H. Robinson Worldwide (CHRW) Lags Q4 Earnings and Revenue Estimates

C.H. Robinson (CHRW) delivered earnings and revenue surprises of -23.70% and 9.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Syneos Health (SYNH) Signs New Partnership With Cryoport

Syneos Health (SYNH) inks a partnership with Cryoport to deliver seamless integration and insights for key services for cell and gene trial operations to biopharmaceutical customers.

CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -15.38% and 13.89%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Schneider National (SNDR) Q3 Earnings Top Estimates

Schneider National (SNDR) delivered earnings and revenue surprises of 4.48% and 2.90%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CryoPort, Inc. (CYRX) Stock Jumps 10.5%: Will It Continue to Soar?

CryoPort, Inc. (CYRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Can CryoPort, Inc. (CYRX) Climb 36% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for CryoPort, Inc. (CYRX) points to a 36.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -13.33% and 0.40%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

Smart Beta ETF report for XHE

Daseke (DSKE) Q2 Earnings Lag Estimates

Daseke (DSKE) delivered earnings and revenue surprises of -36.84% and 9.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?